Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Long-Term Deferred Tax came in at $952.0 million in Q2 2026, down 2.16% on a YoY basis from $973.0 million in Q2 2025, and up 0.74% quarter-over-quarter from $945.0 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Long-Term Deferred Tax for 6 consecutive years, with $952.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Deferred Tax fell 2.16% year-over-year to $952.0 million; the trailing twelve-month figure through Jun 2026 stood at $952.0 million (down 2.16% YoY), and the FY2025 full-year result was $934.0 million, up 5.54% from the prior year.
  • Long-Term Deferred Tax rose to $952.0 million in Q2 2026 per BLCO's latest filing, from $945.0 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $1.0 billion in Q1 2022 and bottomed at $827.0 million in Q2 2024.
  • Historically, Long-Term Deferred Tax has averaged $923.3 million across 5 years, with a median of $925.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax decreased 11.83% in 2024, then rose 17.65% in 2025.
  • Over 5 years, Long-Term Deferred Tax stood at $927.0 million in 2022, then dropped by 0.65% to $921.0 million in 2023, then slipped by 3.91% to $885.0 million in 2024, then rose by 5.54% to $934.0 million in 2025, then rose by 1.93% to $952.0 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $952.0 million, $945.0 million, and $934.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 952.00 Mn
Mar 31, 2026 945.00 Mn
Dec 31, 2025 934.00 Mn
Sep 30, 2025 978.00 Mn
Jun 30, 2025 973.00 Mn
Mar 31, 2025 864.00 Mn
Dec 31, 2024 885.00 Mn
Sep 30, 2024 931.00 Mn
Jun 30, 2024 827.00 Mn
Mar 31, 2024 860.00 Mn
Dec 31, 2023 921.00 Mn
Sep 30, 2023 920.00 Mn
Jun 30, 2023 938.00 Mn
Mar 31, 2023 923.00 Mn
Dec 31, 2022 927.00 Mn
Sep 30, 2022 904.00 Mn
Jun 30, 2022 912.00 Mn
Mar 31, 2022 1.03 Bn
Dec 31, 2021 933.00 Mn